Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Operating Cash Flow per Share : ¥0.08 (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals Operating Cash Flow per Share?

Chengdu Olymvax Biopharmaceuticals's operating cash flow per share for the three months ended in Mar. 2025 was ¥-0.06. Chengdu Olymvax Biopharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.08.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Chengdu Olymvax Biopharmaceuticals was 175.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Chengdu Olymvax Biopharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

During the past 12 years, Chengdu Olymvax Biopharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 23.40% per year. The lowest was 9.70% per year. And the median was 19.50% per year.

SHSE:688319's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.2
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Chengdu Olymvax Biopharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Chengdu Olymvax Biopharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Olymvax Biopharmaceuticals Operating Cash Flow per Share Chart

Chengdu Olymvax Biopharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.06

0.10

-0.06

0.11

-0.02

Chengdu Olymvax Biopharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.16	0.02	-0.01	0.13	-0.06

Competitive Comparison of Chengdu Olymvax Biopharmaceuticals's Operating Cash Flow per Share

For the Biotechnology subindustry, Chengdu Olymvax Biopharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengdu Olymvax Biopharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Olymvax Biopharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chengdu Olymvax Biopharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Chengdu Olymvax Biopharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Chengdu Olymvax Biopharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-9.731	/	405.422
	=	-0.02

Chengdu Olymvax Biopharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-23.504	/	406.547
	=	-0.06

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.08

Chengdu Olymvax Biopharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Olymvax Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.olymvax.com

Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.

Executives

Wu Qiang	Core technical personnel
Chen Dao Yuan	Core technical personnel
Li Hong Guang	Core technical personnel
Fan Shao Wen	Directors, senior managers
Ma Heng Jun	senior management
Wu Wei	senior management
Fan Fan	Director
Chen Ai Min	Director
Tan Yong	senior management
Lu Lu	Director
Yu Yun Hui	Director
Zhang Li Ying	Core technical personnel
Chen Ke Ping	Core technical personnel
Yang Feng	Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines